Extended Survival of Glioblastoma Patients After Chemoprotective HSC Gene Therapy-Reference-Cited by-同舟云学术

Extended Survival of Glioblastoma Patients After Chemoprotective HSC Gene Therapy

Published:2012-05-09 Issue:133 Volume:4 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Adair Jennifer E.¹,Beard Brian C.¹²,Trobridge Grant D.³,Neff Tobias⁴⁵,Rockhill Jason K.⁶⁷,Silbergeld Daniel L.⁶⁸,Mrugala Maciej M.⁶⁹,Kiem Hans-Peter¹²⁸

Affiliation:

1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

2. Department of Medicine, University of Washington, Seattle, WA 98195, USA.

3. Department of Pharmaceutical Sciences, Washington State University, Pullman, WA 99164, USA.

4. Dana-Farber/Children’s Hospital Cancer Center, Boston, MA 02115, USA.

5. Harvard Medical School, Boston, MA 02115, USA.

6. Department of Neurosurgery, University of Washington, Seattle, WA 98195, USA.

7. Department of Radiation Oncology, University of Washington, Seattle, WA 98195, USA.

8. Department of Pathology, University of Washington, Seattle, WA 98195, USA.

9. Department of Neurology, University of Washington, Seattle, WA 98195, USA.

Abstract

Gene therapy using P140K-modified hematopoietic progenitor cells is chemoprotective, enabling glioblastoma patients to withstand myelotoxic doses of chemotherapy.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference40 articles.

1. Phase I Trial of Carmustine Plus O6-Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma

2. Phase I Trial of Temozolomide PlusO6-Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma

3. Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma

4. Long-term polyclonal and multilineage engraftment of methylguanine methyltransferase P140K gene-modified dog hematopoietic cells in primary and secondary recipients

5. Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem Cells and Tumor-Killing Virus to Target Brain Tumor: In Pursuit to Bring a Potential Delivery Vehicle for the Central Nervous System Tumors;Current Drug Delivery;2024-01

2. The DNA Alkyltransferase Family of DNA Repair Proteins: Common Mechanisms, Diverse Functions;International Journal of Molecular Sciences;2023-12-29

3. In vivo selection of anti-HIV-1 gene-modified human hematopoietic stem/progenitor cells to enhance engraftment and HIV-1 inhibition;Molecular Therapy;2023-12

4. Now you see me, now you don’t: New approaches to sparing nonmalignant cells from CAR T cell therapies;Med;2023-11

5. Personalised therapeutic approaches to glioblastoma: A systematic review;Frontiers in Medicine;2023-04-14